Brazil: Demand for GLP-1 companion products in Brazil is projected to grow at around an 11.8% CAGR through 2036, supported by expanding GLP-1 user base for obesity management and diabetes care, and growing demand for high-quality and convenient companion product formats such as sachets, bars, and liquid shots
Vitamin B12 Fact Sheet for Health Professionals. Office of Dietary Supplements, NIH, 11 March 2021, [Full Article] Zheng Y, Cantley LC
Biochem Biophys Res Commun (2015) 463(4):5107
The majority of patients who discontinued SAXENDA due to adverse reactions did so during the first few months of treatment
Also, not every generic may launch immediately in every format
Why Should You Care About GLP-1 Growth